Tag: Cancer: Breast
Biosimilar Promising for ERBB2+ Breast Cancer Treatment
Equivalent response rate for women with ERBB2-positive metastatic breast cancer receiving taxanes
Meds Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling
However, perindopril, bisoprolol do protect against declines in LVEF in HER2-positive early breast cancer
Methylation of Gene Panel May Help Predict Breast CA Survival
High cumulative methylation index linked to shorter median progression-free, overall survival
Palbociclib Efficacious in Metastatic Breast Cancer
Palbociclib-letrozole combination slows disease progression
Cancer Patients Benefit From Exercise During, After Treatment
Studies show better physical function, quality of life for those who did strength training, aerobic activity
Intravaginal Testosterone Deemed Safe in Early Breast CA
Findings in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors
Protein Intake Tied to Modest Survival Advantage in Breast CA
Survival advantage with higher intake of protein, animal protein, regardless of insulin receptor status
Higher Serum Vitamin D Levels Up Survival in Breast Cancer
Link is strongest in premenopausal women, researchers say
Dense-Dose Chemo of Little Benefit in Early Breast Cancer
No statistically significant improvement found in breast cancer recurrence-free survival
Adjuvant Endocrine Tx Adherence Disparity Due to Varying Costs
Racial/ethnic disparities in adherence explained by socioeconomic status, medication costs
